Structure via PubChem · Public domain (PubChem)
ramelteon
Sign in to saveAlso known as Rozerem®, TAK-375, TAK375, (S)-N-[2-(1,6,7,8-tetrahydro-2H-indeno-[5,4-b] furan-8-yl)ethyl]propionamide
Ramelteon, sold under the brand name Rozerem among others, is a melatonin agonist medication which is used in the treatment of insomnia. It is indicated specifically for the treatment of insomnia characterized by difficulties with sleep onset. It reduces the time taken to fall asleep, but the degree of clinical benefit is small. The medication is approved for long-term use. Ramelteon is taken by mouth.
Key facts
- Drug.Verifiedfields
- verified
- Drug.Watchedfields
- verified
- Drug.verifiedrevid
- 464379960
- Drug.image
- Ramelteon skeletal formula.svg
- Drug.image_class
- skin-invert-image
- Drug.image2
- Ramelteon ball-and-stick model.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 200
- Drug.tradename
- Rozerem, others
- Drug.MedlinePlus
- a605038
- Drug.DailyMedID
- Ramelteon
- Drug.dependency_liability
- Low
- Drug.routes_of_administration
- By mouth
- Drug.ATC_prefix
- N05
- Drug.ATC_suffix
- CH02
- Drug.legal_BR
- C1
- Drug.legal_US
- Rx-only
- Drug.bioavailability
- 1.8%
via Wikipedia infobox
Chemical data
- Formula
- C16H21NO2
- Molecular weight
- 259.34 g/mol
- IUPAC name
- N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl]ethyl]propanamide
- SMILES
- CCC(=O)NCC[C@@H]1CCC2=C1C3=C(C=C2)OCC3
- InChIKey
- YLXDSYKOBKBWJQ-LBPRGKRZSA-N
- XLogP
- 2.7
- Polar surface area
- 38.3 Ų
- H-bond donors
- 1
- H-bond acceptors
- 2
- Formal charge
- 0
via PubChem
Wikidata facts
- Mass
- 259.157229
Show 5 more facts
- chemical formula
- C₁₆H₂₁NO₂
- World Health Organisation international non-proprietary name
- ramelteon
- isomeric SMILES
- CCC(=O)NCC[C@@H]1CCC2=C1C3=C(C=C2)OCC3
- canonical SMILES
- CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3
- Commons category
- Ramelteon
via Wikidata · CC0
~13 min read
Article
24 sectionsContents
- Medical uses
- Insomnia
- Circadian rhythm sleep disorders
- Other uses
- Delirium
- Bipolar disorder
- Available forms
- Contraindications
- Adverse effects
- Overdose
- Interactions
- Pharmacology
- Pharmacodynamics
- Mechanism of action
- Pharmacokinetics
- Absorption
- Distribution
- Metabolism
- Elimination
- Special populations
- History
- Society and culture
- Research
- References
Ramelteon, sold under the brand name Rozerem among others, is a melatonin agonist medication which is used in the treatment of insomnia. It is indicated specifically for the treatment of insomnia characterized by difficulties with sleep onset. It reduces the time taken to fall asleep, but the degree of clinical benefit is small. The medication is approved for long-term use. Ramelteon is taken by mouth.
Side effects of ramelteon include somnolence, dizziness, fatigue, nausea, exacerbated insomnia, and changes in hormone levels. Ramelteon is an analogue of melatonin and is a selective agonist of the melatonin MT1 and MT2 receptors. The half-life and duration of ramelteon are much longer than those of melatonin. Ramelteon is not a benzodiazepine or Z-drug and does not interact with GABA receptors, instead having a distinct mechanism of action.
Available in 21 languages
- Español
- Français
- Deutsch
- 中文
- 日本語
- Русский
- Português
- Italiano
- العربية
- Bahasa Indonesia
- Nederlands
- Odia
- Polski
- Romanian
- Serbian
- Serbian (Latin)
- simple
- Tiếng Việt
via Wikidata sitelinks · CC0